Kurze Antwort — Was ist Selank?
Selank is a 7-amino-acid synthetic heptapeptide developed at the Russian Academy of Sciences as an analog of the endogenous immunomodulatory peptide tuftsin. In published studies it acts as an anxiolytic nootropic, modulating GABAergic, serotonergic, and enkephalin signalling and upregulating BDNF expression without the sedation or dependence profile of benzodiazepines. Supplied in 5 mg and 10 mg lyophilized vials.
📦 Jede Bestellung ist durch unsere Reshipment Assurance Policy abgedeckt — wenn Ihr Paket nicht innerhalb von 20 Werktagen ankommt, versenden wir es erneut.
| Spezifikation | Detail |
|---|---|
| CAS-Nummer | 129954-34-3 |
| Molekularformel | C33H57N11O9 |
| Molekulargewicht | 751.88 Da |
| Sequenz | Thr-Lys-Pro-Arg-Pro-Gly-Pro-NH2 (TKPRPGP-NH2, 7 Aminosäuren; C-terminal amidiertes Tuftsin-Analogon) |
| Form | Lyophilisat (weiß bis leicht gelblich) |
| Reinheit | ≥99% (HPLC-bestätigt, COA auf Anfrage) |
| Lagerung | Lyophilisat: 2–8 °C (Kühlschrank) für Arbeitsvorrat; −20 °C zur Langzeitlagerung ungeöffneter Fläschchen. Rekonstituiert: 2–8 °C, innerhalb von ~30 Tagen verwenden. Vor Licht schützen. Die rekonstituierte Lösung nicht einfrieren und auftauen. |
| Löslichkeit | Bacteriostatic water (recommended) or sterile water for shorter use windows. Compatible with intranasal vehicle formulations. |
Was ist Selank?
Selank is a synthetic heptapeptide developed in the 1990s at the Institute of Molecular Genetics of the Russian Academy of Sciences, the same clinical that developed Semax. It is structurally an analog of the endogenous immunomodulatory tetrapeptide tuftsin (TKPR), extended at the C-terminus with a Pro-Gly-Pro tail that confers proteolytic stability and an amidated C-terminus. The tail extension dramatically extends plasma half-life relative to native tuftsin, which is degraded within minutes, while preserving the immunomodulatory activity of the parent peptide. Selank’s well-characterised sequence is TKPRPGP-NH2, Molekulargewicht 751,88 Da, empirische Formel C33H57N11O9. It is supplied as a high-purity lyophilized powder for reconstitution with bacteriostatic water. In Russia, Selank is approved as a prescription anxiolytic under the name Selank (intranasal spray); outside the post-Soviet bloc it is not approved by the FDA, EMA, MHRA, or any other major regulator. For sister-peptide studies, see our Semax Produktseite.
Wirkmechanismus — GABAerge, serotonerge und BDNF-Signalwege
What makes Selank distinctive among anxiolytic compounds is its multimodales neuromodulatorisches Profil ohne direkte Rezeptorbindung an die GABA-A benzodiazepine site — each contributing to the observed anxiolytic and nootropic phenotype in published studies:
- GABAerge Modulation ohne Bindung an die Benzodiazepin-Stelle — Selank potentiates GABA-mediated inhibition through allosteric effects distinct from the benzodiazepine binding pocket. In rodent study models it raises seizure threshold and produces anxiolysis on elevated-plus-maze and open-field tests, but without the sedation, motor coordination loss, dependence liability, or rebound anxiety seen with diazepam. This distinct mode of GABA modulation is the most-studied aspect of Selank’s pharmacology.
- Serotonerge und enkephalinerge Signalübertragung — Published studies has documented increased serotonin metabolism (5-HIAA / 5-HT ratio) in cortical and limbic regions following Selank administration in rodents, alongside upregulation of enkephalin gene expression. The combined serotonergic and enkephalinergic signal is thought to contribute to mood-modulatory and stress-resilience effects in chronic-stress study models.
- BDNF-Expression und Neuroplastizität — Selank raises brain-derived neurotrophic factor (BDNF) expression in the hippocampus and prefrontal cortex in published studies, a mechanism increasingly recognised as central to the long-term effects of mood-modulatory compounds. BDNF upregulation also underpins Selank’s nootropic profile — improved memory consolidation and learning performance in rodent maze tasks.
Selank is intranasally bioavailable (one of the very few peptides with documented mucosal absorption), which is the primary administration route in published Russian and Eastern European studies. The intranasal route bypasses first-pass metabolism and delivers peptide directly across the cribriform plate into central compartments, producing CNS effects within minutes of administration. Subcutaneous administration is also documented in preclinical studies and produces a similar pharmacological profile with slightly slower onset.
Published Evidence
Selank is used in clinical contexts that investigate:
- Anxiolytische Pharmakologie — Elevated-Plus-Maze-, Open-Field- und soziale Interaktions-Tests in Nagetiermodellen generalisierter Angst; Vergleichsarme gegen Benzodiazepine (Diazepam) und SSRIs (Kozlovskaya et al., Eksp Klin Farmakol; Inozemtsev et al., Bull Exp Biol Med)
- Stress resilience and HPA-axis studies — chronischer milder Stress, Restraint-Stress und gelernte-Hilflosigkeits-Modelle; Cortisol- und ACTH-Dynamik
- BDNF and neuroplasticity studies — hippocampale und präfrontale BDNF-Expression, Dendritendornen-Morphologie, Langzeitpotenzierungselektrophysiologie
- Cognitive and memory studies — Morris-Wasserlabyrinth, neuartige Objekterkennung, passive Vermeidung; nootrope Effekte unabhängig von Anxiolyse
- Immunmodulation — Selank inherits tuftsin’s immunomodulatory activity, with documented effects on cytokine balance (TNF-α, IL-6, IFN-γ) and macrophage function in published studies
- Comparative studies vs benzodiazepines — direkter Vergleich mit Diazepam, Alprazolam und Phenazepam hinsichtlich anxiolytischer Wirksamkeit, Abhängigkeitspotenzial und Rebound-Effekten; Selanks sauberes Absetzprofil ist einer der am häufigsten zitierten Befunde in der russischen Literatur
- Sister-peptide studies — Benchmarking gegen Semax (a sister heptapeptide from the same clinical) for nootropic and neuroprotective effects.
For broader context on small-peptide neuromodulation and nootropic studies, see Semax als der kanonische russisch-entwickelte nootrope Vergleichsstoff, Epitalon for pineal-peptide longevity studies, and BPC-157 for the parallel small-peptide healing-compound. Browse the full Peptid-Katalog für verwandte Verbindungen.
Verfügbare Stärken und Konzentrationen
MedsBase stocks Selank in two lyophilized vial sizes calibrated to typical protocol lengths. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats with full reconstitution guidance:
| Vial-Stärke | Typischer Anwendungsfall | Packungsgrößen |
|---|---|---|
| 5 mg | Short protocols, pilot dosing, intranasal-vehicle formulation studies | 10, 20 oder 30 Vials |
| 10 mg | Standard strength, extended protocols, lowest per-mg cost | 10, 20 oder 30 Vials |
Both strengths are the same chemical form (lyophilized powder, 99%+ HPLC purity). Higher-mg vials require smaller reconstitution volumes per unit dose, which is useful when users want to minimise injection or intranasal-delivery volume in rodent protocols.
Vergleich — Selank vs Semax
Selank und Semax are sister peptides developed at the same Russian clinical (Institute of Molecular Genetics, Russian Academy of Sciences) and are often compared in studies because they share heptapeptide architecture, intranasal bioavailability, and Russian regulatory history but differ substantially in primary pharmacological action. Selank is the canonical anxiolytic of the pair; Semax is the canonical nootropic/neuroprotective.
| Kriterium | Selank | Semax |
|---|---|---|
| Länge | 7 Aminosäuren (Heptapeptid) | 7 Aminosäuren (Heptapeptid) |
| Mutterpeptid | Tuftsin (TKPR) | ACTH(4-10)-Fragment |
| Primärer Mechanismus | GABA-Modulation, BDNF, Enkephalin | BDNF, Melanocortin-Rezeptoren, Dopamin |
| Primary signal | Anxiolytisch, Stressresistenz | Nootropikum, neuroprotektiv, Fokus |
| Typical dose (intranasal) | 300–900 µg/Tag | 200–1.000 µg/Tag |
| Klinische Anwendung in Russland | Zugelassenes Anxiolytikum (nasal) | Zugelassenes Nootropikum/Schlaganfallrehabilitation (nasal) |
| Stacking in studies | Häufig mit Semax kombiniert für komplementäre anxiolytische+nootrope Wirkung | Häufig mit Selank kombiniert |
Because the two peptides act on complementary axes — Selank on GABA/anxiolytic, Semax on melanocortin/dopaminergic/nootropic — they are frequently co-administered in protocols investigating cognitive performance under stress, where both arms (calm and focus) contribute to the studied phenotype.
Lagerung und Rekonstitution
Vor der Rekonstitution: Lyophilisierte Fläschchen gekühlt bei 2–8 °C in Originalverpackung für kurzfristigen Gebrauch lagern. Für ungeöffnete Langzeitlagerung bei −20 °C einfrieren. Lyophilisiertes Selank ist unter Kühlung bis zu 24 Monate und bei −20 °C bis zu 36 Monate stabil. Vermeiden Sie Gefrier-Tau-Zyklen des lyophilisierten Pulvers. Rekonstitutionsverfahren: inject bacteriostatic water down the side wall of the peptide vial (not directly onto the lyophilized cake). For a 5 mg vial, 1.0 mL of bacteriostatic water yields a 5 mg/mL working concentration; 0.1 mL delivers a 500 mcg dose. Swirl gently — do nicht shake — and allow 2–5 minutes for full dissolution. A correctly reconstituted solution should be clear and colourless. For intranasal-vehicle formulations, the reconstituted solution can be transferred to a calibrated nasal-spray bottle delivering ~100 μL per pump. gekühlt bei 2–8 °C lagern und innerhalb von 30 Tagen verwenden. Rekonstituierte Lösung nicht einfrieren. Rekonstituierte Lösung bei 2–8 °C kühl lagern und innerhalb von 30 Tagen für optimale Stabilität verwenden. Die rekonstituierte Lösung nicht einfrieren – Gefrier-Tau-Zyklen beeinträchtigen die Peptidintegrität. Fläschchen mit Trübung, Ausfällung oder Verfärbung verwerfen.
Häufig gestellte Fragen
What is Selank used for in studies?
Selank is used in studies investigating anxiolytic pharmacology, stress resilience, BDNF and neuroplasticity, cognitive performance, immunomodulation, and head-to-head comparison against benzodiazepines. It is the most-cited Russian-developed anxiolytic peptide in the literature. The pharmaceutical-grade Selank sold here is nicht FDA-approved and is supplied strictly for clinical studies use only.
Wie unterscheidet sich Selank von Semax?
Both are 7-amino-acid heptapeptides from the same Russian clinical and share intranasal bioavailability, but their mechanisms differ. Selank is derived from the immunomodulatory peptide tuftsin and acts predominantly via GABAergic, enkephalinergic, and BDNF pathways — canonical arm: anxiolysis. Semax is derived from ACTH(4-10) and acts via melanocortin receptors, BDNF, and dopaminergic modulation — canonical arm: nootropic and neuroprotection. The two are frequently co-administered in studies because the effects are complementary rather than overlapping.
What is the typical Selank dose?
Published Russian protocols typically use 300–900 mcg per day administered intranasally in 3 divided doses, or equivalent subcutaneous doses. A 5 mg vial reconstituted with 1.0 mL bacteriostatic water yields 5 mg/mL — 0.1 mL equals 500 mcg, a typical single-dose studies aliquot.
Ist Selank von der FDA zugelassen?
No. Selank is not approved by the FDA, EMA, MHRA, or any major Western regulator. It is approved in Russia as a prescription anxiolytic under the brand name Selank (intranasal spray, ZAO Pharm-Sintez).
Wie sollte Selank gelagert werden?
Lyophilisierte Fläschchen: gekühlt bei 2–8 °C für kurzfristige Arbeitsbestände oder −20 °C für die Langzeitlagerung ungeöffneter Fläschchen. Rekonstituierte Lösung: gekühlt bei 2–8 °C, innerhalb von 30 Tagen verwenden. Rekonstituierte Lösung nicht einfrieren – Gefrier-Auftau-Zyklen degradieren das Peptid. Immer vor direktem Licht schützen.
Wie rekonstituiere ich Selank?
Befolgen Sie das oben beschriebene Rekonstitutionsverfahren. Geben Sie bakterienstatisches Wasser an der Seitenwand des Fläschchens hinzu (nicht auf den lyophilisierten Kuchen), schwenken Sie vorsichtig und lassen Sie 2–5 Minuten zur vollständigen Auflösung. Schütteln Sie nicht Schütteln Sie das Fläschchen nicht. Eine korrekt rekonstituierte Lösung ist klar und farblos. Bei einem 5 mg-Fläschchen + 1,0 mL Verdünnungsmittel beträgt die Arbeitskonzentration 5 mg/mL.
Welche Stärken führt MedsBase?
MedsBase carries Selank in 5 mg and 10 mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis available on request.
Can Selank be administered intranasally in studies?
Yes — intranasal administration is the primary administration route in Russian and Eastern European published studies. Selank is one of the few peptides with documented intranasal bioavailability, attributable to its small size (7 aa, ~752 Da) and amidated C-terminus. The route bypasses first-pass metabolism and delivers peptide across the cribriform plate into central compartments within minutes of administration. Subcutaneous and intramuscular routes also work in preclinical models.
Can Selank and Semax be stacked in studies?
Yes. Selank and Semax are frequently co-administered in published studies because their mechanisms are complementary. Selank provides anxiolytic and stress-buffering effects via GABA/enkephalin/BDNF pathways; Semax provides nootropic and neuroprotective effects via melanocortin/dopaminergic/BDNF pathways. The combination is particularly studied in study models of cognitive performance under stress.
Does Selank cause side reported effects?
Published preclinical and Russian clinical studies has reported a notably clean safety profile at typical doses, with no consistent sedation, motor-coordination effects, dependence liability, or rebound on discontinuation — in clear contrast to benzodiazepine comparator arms. Long-term safety data outside Russia is limited because the peptide has not undergone Western regulatory review.
Wie ist die Halbwertszeit von Selank?
In preclinical studies, Selank has an estimated plasma half-life of approximately 15–30 minutes following intranasal administration, far longer than the parent peptide tuftsin (under 5 minutes). The short plasma half-life is offset by central-compartment accumulation following intranasal delivery and downstream effects on BDNF and gene expression that persist beyond plasma clearance.
How long does Selank take to show effects in preclinical studies?
Acute anxiolytic effects on elevated-plus-maze and open-field tests are detectable within 30–60 minutes of intranasal administration. BDNF and gene-expression effects accumulate over 7–14 days of regular dosing and underpin the longer-term mood-modulatory and nootropic phenotype observed in chronic-stress study models.
Kann ich Selank für den internationalen Versand bestellen?
Ja. MedsBase versendet Selank weltweit über unser spezielles Peptid-Versandnetzwerk. Bestellungen ausschließlich mit Peptiden qualifizieren sich für unseren eigenständigen Peptidversandservice. Alle Sendungen werden in temperaturkontrollierter Verpackung mit vollständiger Sendungsverfolgung versandt und sind durch unsere Reshipment Assurance Policy.
Other Peptides for Nootropic, Neuroprotective, and Cognitive Studies
- Semax — Sister heptapeptide from the same Russian clinical — nootropic and neuroprotective studies
- Epitalon — AEDG pineal tetrapeptide — longevity and circadian rhythm support
- BPC-157 — Body Protection Compound — healing and tissue-recovery
- KPV — Small immunomodulatory tripeptide — inflammation and barrier studies
- Adamax — Heptapeptide nootropic compound
Weiterführende Literatur
📖 Explore small-peptide nootropic studies
Durchstöbern Sie das gesamte Sortiment Peptid-Katalog, mit verwandten Verbindungen einschließlich Semax for melanocortin-axis nootropic studies, Epitalon for pineal-peptide longevity studies, and Adamax for sister heptapeptide cognitive studies.














Bewertungen
Es gibt noch keine Bewertungen.